Gynecologic Oncology | Max Hospital
  1. Home
  2. Taxonomy
  3. Gynecologic Oncology

Get Second Opinion

Please provide your phone number with country code

2 + 4 =

Doc Connect

Hospital : 
Max Super Speciality Hospital, Saket
  • Robotic Urological Surgery: 15 years journey 
    Dr. Rahul Yadav, Dr. Anant Kumar
  • Robotic surgery is the latest in advanced onco surgical procedures 
    Dr. Harit Chaturvedi
  • Percutaneous balloon aortic valvuloplasty & balloon dilatation of aortic coarctation in a 10 year old child 
    Dr. Neeraj Awasthy, Dr. Sushil Shukla
  • Role of CT/MR imaging and echocardiography in evaluation of valsalva sinus aneurysm 
    Dr. Reena Anand, Dr. Raj Kumar, Dr. Divya Malhotra, Dr. Bharat Aggarwal
  • Risk factors for patients undergoing treatment for Breast Cancer
    Ms. Kanika Arora, Ms. Ritika Samaddar
  • Radiology Case of The Month 
    Dr. Nafisa Shakir Batta, Dr. Dhruv Jain
October, 2015 :15
Emergency Call Button

DELHI / NCR : 011-4055 4055

MOHALI : 77107-77107

DEHRADUN : 0135 719 3333

BATHINDA : 0164-5212000



Bio Medical Waste Report For Shalimar Bagh

Month Red Autoclave(Infected Plastic Waste) Yellow- Incineration(AnatomicalWaste & Soiled Waste) Blue Autoclave (Glass- Bottles) Black Cytotoxic- Incineration( Cytotoxic Contaminated Items) White- Sharp Total Bags Total Weight(In KG's)
  No. of Bags Weight (in KG's) No. of Bags Weight (in KG's) No. of Bags Weight (in KG's) No. of Bags Weight (in KG's) No. of Bags Weight (in KG's)    
Apr-17 924 2963.50 954 2994.10 239 1017.30 103 279.20 1645 606.40 3865 7861.00
May-17 1175 4624.12 1028 3498.40 276 1524.34 87 195.01 1803 823.85 4369 10665.71
Jun-17 1060 4511.45 902 2886.66 293 1324.05 76 194.00 2057 1100.69 4388 10016.85
Jul-17                     0 0.00
Aug-17                     0 0.00
Sep-17                     0 0.00
Oct-17                     0 0.00
Nov-17                     0 0.00
Dec-17                     0 0.00
Jan-18                     0 0.00
Feb-18                     0 0.00
Mar-18                     0 0.00
YTD 3159 12099.065 2884 9379.155 808 3865.69 266 668.705 5505 2530.94 12622 28543.555

Gynecologic Oncology

Home >> Taxonomy >> Gynecologic Oncology

Clinical Directorate

For more info please call 8744 888 888 (Delhi – NCR) & 9988 422 333 (Chandigarh Tri-city), or mail at

Gynaecologic Cancer care - in the times of Pandemic

May 26, 2020 0 2 minutes, 54 seconds read

Providing care for patients with cancer during this crisis is arduous, given the battling risks of death from cancer versus death or serious complications from SARS-CoV-2, and the likely higher lethality of COVID-19 in immunocompromised hosts.

Finding a fine balance, weighing the risks and benefits for each patient and customising care is needed like never before. Relying on observational data and the experience of countries ahead of us in timeline and numbers, there are no blanket or one-stop guidelines given how fluid and dynamic the situation is. The general principle is to balance the risk of cancer progression against the risk of Covid-19 infection while assessing the potential benefits of treatment by various modalities like surgery, chemotherapy and radiation therapy. Many patients with cancer are tussling to receive treatment for their cancers as hospital care is diverted for tackling the emerging pandemic. 

Salient points one need to check while finding this special balance in these testing times:

Newly diagnosed gynaecologic cancer patients during the pandemic

Deciding whom to treat, for patients who are newly diagnosed/ need work-up for evaluation of cancer needs to emphasised and a policy of including all is necessary to prevent undue harm from cancer progression

  • Include every patient to begin cancer treatment if the potential oncological benefit is clinically significant ‒ if it is potentially curative, or effective against metastatic disease, or even if there is an immediate need for palliating symptomatic disease.
  • However, the decision must be personalised, in discussion with each patient, according to the risk‒benefit factors of the patient and their disease.
  • There are no guidelines, and decisions are made on the basis of basic principles, ethics and common sense, with thorough discussions involving all multidisciplinary team members, taking inputs from patients and their caregiver in an open transparent way is the essence of treatment in times of pandemic. 

Existing gynaecologic cancer patients during the pandemic

  • As a general rule, and where adequate precautions are in place, it is important to continue cancer treatment rather than delay for fear of infection. Such clarity comes from institutes with published guidelines. There isn’t evidence to stop or change a line of management a patient is already receiving, while we counteract the risks of infection.
  • Use our own clinical judgement and personalising care.  Consider the prognosis of the patient and weigh the chances the therapy will really help them and tailor needs accordingly
  • As usual, all decisions should be reached in full and open discussion with the patient by gathering as much information from the patient and their care-givers to fully understand their apprehensions on both sides.
  • For our patients on follow-up, reassuring over teleconsults, managing symptoms, if any and protecting their general well being is more important now than ever. 
  • This is an especially stressful time for our patients and we need to help them manage stress, anxiety by honest discussions in an empathetic way. The need for multiple discussions while they decide cannot be overemphasised, preferably as teleconsults as we limit hospital visits. 
  • Having virtual support group meetings addressing common issues faced by women with gynaecologic cancers. Also gives strength, bonding and a sense of feeling that they are not alone in this time of crisis. 

While we have the ‘new normal’ ways of interacting and connecting, we hope to keep this transition smooth and seamless to ensure utmost physical and mental well being of our patients and their care-givers too. 

Author is a Consultant, Gynaecologic Oncologist at Max Institute of Cancer Care, Max Hospital , Saket​

Related Articles

Featured Doctors

Best Cancer Specialist in Delhi, India - Dr. Kanika B Modi - Max Hospital
Consultant – Gynaecologic Oncology

Dr. Siddharth Kumar Sahai

Share This: 


Biographical Sketch: 

Dr. Siddharth Kr. Sahai is a Senior Medical oncologist, trained from all India Institute of medical Sciences (AIIMS), Delhi. He has an experience of 16 + years in managing patients. He has worked and holds teaching experience from most prestigious medical institutions of India like MAMC (Delhi), AIIMS (Delhi) and LHMC (Delhi). Dr. Siddharth Kr. Sahai has rich experience of diagnosing and managing cancer patients. He has in depth knowledge Hormone therapy and Autologus Stem cell Transplant .


Work Experience: 
  • 16+ years of experience in clinical management of cancer patients
  • 2018 to 2020 – Consultant Medical Oncology , Manipal Hospital , Delhi
  • 2016 to 2018—Senior Consultant , Medical Oncology , Paras Hospital , Gurgaon 
  • 2013 to 2016 – Consultant Medical Oncology FMRI , Gurgaon
Education & Training: 
  • ESMO Certified
Speciality Interest: 
  • Breast Oncology
  • Gynaecological Maligancies (cancer of ovaries, fallopian tubes, uterus, cervix, vagina etc)
  • Head & Neck cancers
  • Targeted Therapy & Immunotherapy
  • Uro-Oncology (Prostate Cancer, Urinary Bladder Cancer, Kidney Cancer etc)
  • Targeted treatment and immunotherapy in lung cancer and sarcoma 
Duration Of OPD: 
  • 9 AM- 5 PM

Dr. Manash Biswas

Dr. Manash Biswas
Associate Director - Gynaecology Onco Surgery
Manash Biswas
  • Association of Gynaecologic Oncologists of India (AGOI) (Life Member)
  • International Gynecologic Cancer Society (IGCS)
  • Indian Society of Peritoneal Surface Malignancies (Life Member)
  • Indian Society of Colposcopy & Cervical Pathology (ISCCP) (Life Member)
  • Delhi Oncology Forum (Life Member)
  • Association of Obstetricians and Gynaecologists of Delhi (AOGD)
  • Federation of Obstetric & Gynaecological Societies of India (FOGSI)
Share This: 


Work Experience: 
  • 14 years of experience as Gynaecologic Oncologist in the Armed Forces Medical Services
  • Experience in the Cancer Care Team of Quartinery Care Hospitals of the Armed Forces Medical Services – Army Hospital Research & Referral Delhi,AFMC & Command Hospital Pune and Command Hospital (AF) Bangalore
  • Professor & Head at Dept of Obstetrics & Gynaecology, Armed Forces Medical College, Pune
  • Associate Director Gynae Onco Surgery at Max Institute of Cancer Care, Max Super Speciality Hospital, Saket, New Delhi since Jul 2019
  • Currently, Vice President of ‘Association of Gynaecologic Oncologists of India’
Education & Training: 
  • MBBS, Armed Forces Medical College, Pune
  • MD(Obs&Gyn), Armed Forces Medical College, Pune
  • Fellowship Gynaecologic Oncology, Tata Memorial Hospital, Mumbai, 2003
  • Visiting Clinician, Division of GynOnco Surgery,Mayo Clinic, Rochester, 2010
  • GyneOnco Minimal Access Workshop at Indo American Hospital, Hyderabad (2013)
  • International Course Workshop on CRS & HIPEC, TMH Mumbai
  • FICRS, Fellowship Training in Robotic Surgery, WLH, Gurgaon
Awards Information: 
  • Awarded the Chief of Air Staff’s Commendation Medal in 2013
Speciality Interest: 
  • Aggressive Cytoreductive Surgery & HIPEC in Ovarian Cancer
  • Minimal Access Surgery in GynaeOnco (Laparoscopic & Robotic)
  • Surgery in Vaginal &Vulval Cancer
Duration Of OPD: 

       Max Super Speciality Hospital, Saket

  • Mon –    8AM – 10 AM
  • Tue –     12 AM – 2 PM
  • Wed –     9 AM – 11 AM,  5PM – 7PM
  • Thurs – 9AM – 11 AM, 
  • Fri –       2PM – 4 PM
  • Sat –      10 AM – 12 AM

       Max Lajpat Nagar

  • Thursday – 4PM – 5 PM
Research & Publication: 
  • Referee and Reviewer of publications – MJAFI & IJGO
  • Original work - Neoadjuvant Chemotherapy in Cancer  Cervix - A  Phase 2 trial
  • Risk of Malignancy Index to evaluate adnexal masses for purpose of referring patients to Gyanecologic Oncology centers of Armed Forces
  • Correlation of HPV DNA Hybridization study using hybrid capture 2 technology with video Colposcopy and PAP smear in cases of cervical dysplasia
  • 26 articles including 5 chapters in books. Articles are in peer – reviewed International (01) and National Journals (21)

Dr. Sharan Choudhri

Dr. Sharan Choudhri
Associate Director- Surgical Oncology
Dr. Sharan Choudhri - Max Hospital
  • Indian Association of Surgical Oncology (IASO)
  • Indian Society of Oncologists (ISO)
  • International Union for Control of Cancer (UICC)
  • Association of Armed Forces Surgeons (AAFS)
  • Association of Surgeons of India (ASI)
  • Indian Society of Aero-Space Medicine (ISAM)
  • Association of Minimal Access Surgeons of India (AMASI)
Share This: 


Work Experience: 
  • Professor (Dr) Sharan Choudhri is a Surgical Oncology and Surgery, with a wealth of knowledge and clinical experience accumulated in a career spanning over three decades in the Army Medical Corps. He established the first Malignant Diseases Treatment Centre for the Indian Air Force at Command Hospital Air Force, Bangalore, and the Oncology Centre at Base Hospital Delhi Cantt. He honed his operative skills and clinical acumen in the Services where he rose to appointment of Senior Advisor in Surgical Oncology and Surgery to the entire Indian Armed Forces. Subsequently he was appointed as Professor and HOD at the Dharamshilla Cancer Hospital, and later at Saket City Hospital before his present appointment
Education & Training: 
  • After obtaining his Graduation and Masters Qualifications from Armed Forces Medical College, Pune, he acquired training in Surgical Oncology at the Malignant Diseases Treatment Centre, INHS Asvini (the premier Naval Command Hospital at Mumbai), and at the Tata Memorial Hospital, Mumbai.
  • Subsequently he was trained in Esophageal Surgery at Kurume Medical University, Fukuoka, Japan; and in Hepato-Biliary Surgery at Shimane Medical University, Izumo, Japan & Memorial Sloan Kettering Cancer Center, New York, USA. He also visited the Michigan State University, Flint, Michigan, USA to gain expertise in Sentinel Lymph Node Technique, a recent technique aimed to minimize surgical morbidity in a variety of cancers.
Awards Information: 


  • UICC—ICRETT Fellowship Award 1994 At Kurume Medical University, Kurume, Japan as Visiting Fellow For “Three-Field Lymphadenectomy For Esophageal Malignancies”
  • UICC—ICRETT Fellowship Award 2001 To carry out Research Project on “Sentinel Lymph Node Mapping & Biopsy In Surgical Oncology – Its Technique, Pitfalls And Outcome” at Michigan State University, Flint, Michigan, USA
  • “Young Investigators Award” at the 3rd International Sentinel Node Congress at Yokohama, Japan 16 – 18 Nov 2002 where the Presentation on “Promise & Pitfalls of Sentinel Lymph Node Biopsy in Oral Malignancies” was selected for Outstanding Scientific Merit, Innovation And Educational Value, And Promotion Of Sentinel Node Navigation Surgery


  • Air Vice Marshal MM Shrinagesh Memorial Medal for standing First in Surgery in Medical Officers Junior Command Course – 1986
  • Prizes at the “Onco-Quiz” At National Conference of Indian Association of Surgical Oncology on several occasions (1999, 2000, 2005)
  • Sectional Editor, Indian Journal of Surgery for the “Association of Armed Forces Surgeons” a Section of the Association of Surgeons of India
  • Elected Member of Executive Committee of the Indian Association of Surgical Oncology for two years (2002-2003)
Speciality Interest: 
  • Cancers of the Gastro-intestinal tract including esophagus
  • Hepato-biliary-pancreatic cancers
  • Cancers of the female genital tract
  • Minimally Invasive Cancer Surgery
Duration Of OPD: 

  Max Smart Super Specialty Hospital Saket

  • Tuesday:   12 pm to 2 pm
  • Thursday:  10 am to 12 pm
  • Saturday:   10 am to 12 pm

  Max Cancer Centre, Lajpat Nagar

  • Monday:    3 pm to 4 pm
  • Friday:         3 pm to 4 pm

Dr. Prekshi Chaudhary

  • AROI (Association of Radiation Oncologists of India)
  • U P Medical Council
  • Delhi Medical Council
  • Oncology forum, Delhi NCR
Share This: 


Work Experience: 
  • Associate Consultant- Max Super Speciality Hospital, Vaishali
  • Attending Consultant- Max Super Speciality Hospital, Vaishali
  • Senior Residency- Pushpanjali Crosslay Hospital
Education & Training: 
  • MBBS- King George Medical College, Lucknow
  • MD- S.N. Medical College, Agra
  • Visiting Scholar in S.G.P.G.I. Lucknow
Awards Information: 
  • Honors in Medicine and Pediatrics
  • Has done publications in renowned journals
Speciality Interest: 
  • Breast, thoracic and gynaecological malignancies
Duration Of OPD: 

       Max Super Speciality Hospital, Vaishali

  • Tuesday, Thursday & Saturday – 10 am to 2 pm

       Max Multi Speciality Centre, Noida

  • Wednesday- 11 am to 1pm
  • Friday 2 pm to 4pm

Dr. Shefali Sardana


View other oncologists in Delhi.

Share This: 


Work Experience: 
Education & Training: 
Awards Information: 
Speciality Interest: 
Duration Of OPD: 


  • Monday - 9:00 AM to 12:30 PM
  • Tuesday - 9:00 AM to 12:30 PM
  • Wednesday - 9:00 AM to 12:30 PM
  • Thursday - 9:00 AM to 12:30 PM
  • Friday - 9:00 AM to 12:30 PM
  • Saturday - 9:00 AM to 12:30 PM

Dr. Kanika Batra Modi

Dr. Kanika Batra Modi
Consultant – Gynaecologic Oncology
Best Cancer Specialist in Delhi, India - Dr. Kanika B Modi - Max Hospital
  • AGOI
  • IGCS
  • ASCO
  • ASGO
  • AOGD
  • FOGS

View other cancer specialists in Delhi.

Share This: 


Work Experience: 
  • MBBS– Maulana Azad Medical College
  • Post Grad – Safdarjung Hospital & VMMC (2011)
  • Senior Resident – Rajiv Gandhi Cancer Institute and Research Centre
  • Fellowship (IGCS) Royal Hospital for Women, Sydney 2016
  • Fellowship Gynae Oncology, RGCIRC
  • Ex- Visiting Physician, Mayo Clinic, Rochester, 2017
  • Fellow IARC, IFCPC
  • Colposcopy and Pre-invasive Cervical lesions Training, Royal Hospital, Sydney
Education & Training: 
  • MBBS, DNB-MS, Fellowship Gynaecology Oncology
  • Fellow (IGCS), Gynaecology Oncology, Royal Hospital for Women, Sydney
Awards Information: 
  • Best Oral Presentation ISCCP, 2017, “ Analysis of the predictive role of lymph node density, negative lymph node and LODDS on the survival of cervical cancer patients”
  • Best Video presentation AGOICON, 2017, “Development of parametrium in cervical cancer”
  • Best Poster presentation AGOICON, 2017 “Role of PET/CT in recurrent ovarian cancer
  • Best Oral presentation RGCON, 2016 “.Recurrent Cancer of the Vulva: Clinicopathologic Prognostic Factors, Patterns of Recurrence, and Their Management”
  • Best Video presentation RGCON, 2016 “ Retroperitoneal Lymph Node Dissection in cancer endometrium”
Duration Of OPD: 

   Max Institute of Cancer Care, Lajpat Nagar

  • Saturday-  9.30am to 11am

   Max Super Speciality Hospital, Saket

  • Mon, Wed, Friday: 3.00 pm – 5:00 pm
  • Tues, Thursday: 10.00 am – 12.00 noon
Research & Publication: 
  • Retrograde Hysterectomy for Benign Gynaecologic Conditions Kanika Batra Modi, Rupinder Sekhon ,AOGD bulletin, Volume 17, Issue 3, July 2017
  • Vulvar carcinoma: dilemma, debates, and decisions. Cancer management and research.  Mitra S, Sharma MK, Kaur I, Khurana R, Modi KB, Narang R, Mandal A, Dutta S. 2018;10:61
  • Recurrent Cancer of the Vulva: Clinicopathologic Prognostic Factors, Patterns of Recurrence, and Their Management. Batra Modi K, Sekhon R, Shah S, Giri S, Jain V, Mitra S, Rawal SJournal of Gynecologic Surgery. 2016 Dec 1;32(6):339-44
  • Recent advances in Gynae-oncology Rupali Dewan , Abhinav Dewan, Kanika Batra , AOGD bulletin, December 2015
  • Role of PET/CT in recurrent ovarian cancer Batra K, Sekhon R, Rawal S, Giri S.. international journal of gynecological cancer 2016 Oct 1 (Vol. 25, No. 9, pp. 1289-1289)
  • Presentation and Management of Inguinal Lymphadenopathy in Ovarian Cancer Giri, S., Shah, S.H., Batra, K. et al. Indian J Surg Oncol (2016). doi:10.1007/s13193-016-0556-7
Book an Appointment